Error message
Notice: Undefined index: content in _drupal_default_html_head() (line 345 of /var/www/vhosts/rovi.es/httpdocs/includes/common.inc).
|
Date |
Title |
Description |
PDF |
|
22 Feb 2022 |
On buy-back programmes |
ROVI reports the end of the share buy-back programme, effective as of 3 November 2021, and the launching of a new share buy-back programme, effective as of 23 February 2022.
|
Download |
|
16 Feb 2022 |
On business and financial situation |
Moderna and ROVI announced that they expand their long-term collaboration for the manufacture of mRNA medicines over the next ten years
|
Download |
|
03 Nov 2021 |
On buy-back programmes |
The Company reports the commencement, effective as of today, 3 November 2021, of a share buyback program.
|
Download |
|
16 Jul 2021 |
On Corporate Governance |
ROVI announces the appointment of Juan López-Belmonte Encina as Chairman of the Company
|
Download |
|
22 Jun 2021 |
On significant placements in financial instruments |
Hereby inform of the completion of the private placement package. The amount of the Placement amounted to a total of 87.88 million euros, being the unit selling price of 52.25 euros per share.
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
08 May 2025 |
On business and financial situation |
The Company releases the first three months 2025 financial results presentation
|
Download |
|
08 May 2025 |
Announcement of General Shareholders’ Meeting |
The Company announces the call of its 2025 Ordinary General Shareholders' Meeting
|
Download |
|
08 May 2025 |
On business and financial situation |
ROVI informs on the award of a grant in its favor to develop the R&D Project IPCEI - ROVI (LAISOLID)
|
Download |
|
04 Apr 2025 |
Liquidity and counterparty agreements |
Liquidity contract: transactions conducted in the first quarter of 2025
|
Download |
|
25 Feb 2025 |
Annual Financial Reports and Audit Reports |
The Company submits the 2024 Annual Financial Report
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
08 Oct 2018 |
Share capital increases and reductions |
Information on the registration in the Commercial Registry of Madrid of the notarial deed regarding the capital increase
|
Download |
|
05 Oct 2018 |
Buy-back programmes, stabilisation and treasury stock |
Information about the possibility that Jefferies International Limited carries out stabilisation transactions within the framework of the capital increase excluding pre-emptive subscription rights of the existing shareholders of Laboratorios Farmacéuticos Rovi, S.A.
|
Download |
|
04 Oct 2018 |
Share capital increases and reductions |
Directors’ Report and Independent Expert Report related to capital increase excluding preferential subscription rights
|
Download |
|
04 Oct 2018 |
Liquidity contracts and specialists |
The Company informs that has temporarily suspended liquidity agreement with JB Capital Markets, Sociedad de Valores, S.A.U.
|
Download |
|
04 Oct 2018 |
Share capital increases and reductions |
Information on price fixing and outcome of the private placement related to capital increase addressed to institutional investors, excluding preferential subscription rights
|
Download |
Pages
